D. E. Shaw & Co., Inc. Neuronetics, Inc. Call Options Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STIM
# of Institutions
95Shares Held
18.6MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.74MShares$7.24 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$4.59 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.51MShares$3.98 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$2.9 Million1.17% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$2.64 Million0.14% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $71.3M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...